Literature DB >> 16902376

Prevalence of workplace exacerbation of asthma symptoms in an urban working population of asthmatics.

Zackary Berger1, W N Rom, J Reibman, M Kim, S Zhang, L Luo, George Friedman-Jiménez.   

Abstract

OBJECTIVES: We used an interviewer-administered questionnaire to investigate workplace exacerbation of asthma symptoms (WEAS) among low-income, minority, working asthmatics admitted Bellevue Hospital Center in New York City from 2001 to 2002. We hypothesized that a high prevalence of WEAS would be found in this population among all jobs held and a subset of individual occupational classifications.
MEASUREMENTS AND MAIN RESULTS: Of 301 subjects, 51% reported WEAS in their current or most recent job; 71% reported WEAS in any job. Prevalences (95% confidence intervals) of WEAS in common job classifications were 61% (49-73%) in janitorial jobs, 50% (33-67%) in garment and textile manufacturing jobs, and 38% (23-55%) in construction jobs.
CONCLUSION: WEAS is prevalent in this urban minority population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902376     DOI: 10.1097/01.jom.0000225169.45337.97

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  8 in total

Review 1.  Diagnosis of occupational asthma: an update.

Authors:  Edgardo J Jares; Carlos E Baena-Cagnani; R Maximiliano Gómez
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

Review 2.  A review of equity issues in quantitative studies on health inequalities: the case of asthma in adults.

Authors:  Heather L Greenwood; Nancy Edwards; Amandah Hoogbruin; Eulalia K Kahwa; Okeyo N Odhiambo; Jack A Buong
Journal:  BMC Med Res Methodol       Date:  2011-07-12       Impact factor: 4.615

3.  Cleaning products and short-term respiratory effects among female cleaners with asthma.

Authors:  David Vizcaya; Maria C Mirabelli; David Gimeno; Josep-Maria Antó; George L Delclos; Marcela Rivera; Ramon Orriols; Lourdes Arjona; Felip Burgos; Jan-Paul Zock
Journal:  Occup Environ Med       Date:  2015-04-23       Impact factor: 4.402

4.  Occupational exposures, smoking and airway inflammation in refractory asthma.

Authors:  Jodie L Simpson; Maya Guest; May M Boggess; Peter G Gibson
Journal:  BMC Pulm Med       Date:  2014-12-19       Impact factor: 3.317

5.  Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study.

Authors:  Jeong-Lim Kim; Paul K Henneberger; Susanna Lohman; Anna-Carin Olin; Anna Dahlman-Höglund; Eva Andersson; Kjell Torén; Mathias Holm
Journal:  BMC Pulm Med       Date:  2016-11-15       Impact factor: 3.317

6.  Low dose of chlorine exposure exacerbates nasal and pulmonary allergic inflammation in mice.

Authors:  Isabella Santos de Genaro; Francine Maria de Almeida; Deborah Camargo Hizume-Kunzler; Henrique Takachi Moriya; Ronaldo Aparecido Silva; João Carlos Gonçalves Cruz; Renan Boeira Lopes; Renato Fraga Righetti; Rodolfo de Paula Vieira; Mitiko Saiki; Milton Arruda Martins; Iolanda de Fátima Lopes Calvo Tibério; Fernanda Magalhães Arantes-Costa; Beatriz Mangueira Saraiva-Romanholo
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

7.  Clinical Importance of Work-Exacerbated Asthma: Findings From a Prospective Asthma Cohort in a Highly Industrialized City in Korea.

Authors:  Woori Jo; Kwang Won Seo; Hwa Sik Jung; Chui Yong Park; Byung Ju Kang; Hyeon Hui Kang; Seung Won Ra; Yangjin Jegal; Jong Joon Ahn; Soon Eun Park; Moon Sik Jung; Ju Ik Park; Eun Ji Park; Chang Sun Sim; Tae Bum Kim; Taehoon Lee
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

8.  Olfactory Receptors Modulate Physiological Processes in Human Airway Smooth Muscle Cells.

Authors:  Benjamin Kalbe; Jürgen Knobloch; Viola M Schulz; Christine Wecker; Marian Schlimm; Paul Scholz; Fabian Jansen; Erich Stoelben; Stathis Philippou; Erich Hecker; Hermann Lübbert; Andrea Koch; Hanns Hatt; Sabrina Osterloh
Journal:  Front Physiol       Date:  2016-08-04       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.